Literature DB >> 15180563

Heme oxygenase-1: a novel therapeutic target in oxidative tissue injuries.

T Takahashi1, K Morita, R Akagi, S Sassa.   

Abstract

Oxidative stresses such as oxidant stimuli, inflammation, exposure to xenobiotics, or ionizing irradiation provoke cellular protective responses, principally involving transcriptional activation of genes encoding proteins which participate in the defense against oxidative tissue injuries. Excess of free heme, which is released from hemeproteins under such conditions, may constitute a major threat because it can catalyze the formation of reactive oxygen species (ROS). Exposure of mammalian cells to oxidative stimuli induces heme oxygenase-1 (HO-1), the rate-limiting enzyme in heme degradation, as well as a 33-kDa heat shock protein. In various model systems, HO-1 induction confers protection on tissues from further injuries, while the abrogation of its induction accelerates cellular injuries. In this article, we review recent advances in the regulatory mechanism of ho-1 gene expression and the role of HO-1 in various models of experimental oxidative tissue injuries, and its potential therapeutic implications.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15180563     DOI: 10.2174/0929867043365080

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  48 in total

1.  Compound C stimulates heme oxygenase-1 gene expression via the Nrf2-ARE pathway to preserve human endothelial cell survival.

Authors:  Xiao-Ming Liu; Kelly J Peyton; Ahmad R Shebib; Hong Wang; William Durante
Journal:  Biochem Pharmacol       Date:  2011-05-24       Impact factor: 5.858

2.  Upregulation of heme oxygenase-1 by acteoside through ERK and PI3 K/Akt pathway confer neuroprotection against beta-amyloid-induced neurotoxicity.

Authors:  Hong-Quan Wang; Yu-Xia Xu; Cui-Qing Zhu
Journal:  Neurotox Res       Date:  2011-12-07       Impact factor: 3.911

3.  Stress under the dam: meeting report of the Fourth International Workshop on the Molecular Biology of Stress Responses.

Authors:  R William Currie; Tangchun Wu; Robert M Tanguay
Journal:  Cell Stress Chaperones       Date:  2004       Impact factor: 3.667

4.  Lutein prevents high fat diet-induced atherosclerosis in ApoE-deficient mice by inhibiting NADPH oxidase and increasing PPAR expression.

Authors:  Hao Han; Wei Cui; Linzhi Wang; Yufang Xiong; Liegang Liu; Xiufa Sun; Liping Hao
Journal:  Lipids       Date:  2015-02-07       Impact factor: 1.880

5.  Tuberous sclerosis complex activity is required to control neuronal stress responses in an mTOR-dependent manner.

Authors:  Alessia Di Nardo; Ioannis Kramvis; Namjik Cho; Abbey Sadowski; Lynsey Meikle; David J Kwiatkowski; Mustafa Sahin
Journal:  J Neurosci       Date:  2009-05-06       Impact factor: 6.167

6.  Effects of dexmedetomidine pretreatment on heme oxygenase-1 expression and oxidative stress during one-lung ventilation.

Authors:  Shenqiang Gao; Yuelan Wang; Jun Zhao; Aiping Su
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

7.  Inducing Heat Shock Proteins Enhances the Stemness of Frozen-Thawed Adipose Tissue-Derived Stem Cells.

Authors:  Shahensha Shaik; Daniel Hayes; Jeffrey Gimble; Ram Devireddy
Journal:  Stem Cells Dev       Date:  2017-02-16       Impact factor: 3.272

8.  Human heme oxygenase-1 efficiently catabolizes heme in the absence of biliverdin reductase.

Authors:  James R Reed; Warren J Huber; Wayne L Backes
Journal:  Drug Metab Dispos       Date:  2010-08-02       Impact factor: 3.922

9.  Heat shock proteins and mitogen-activated protein kinases in steatotic livers undergoing ischemia-reperfusion: some answers.

Authors:  Marta Massip-Salcedo; Araní Casillas-Ramirez; Rosah Franco-Gou; Ramón Bartrons; Ismail Ben Mosbah; Anna Serafin; Joan Roselló-Catafau; Carmen Peralta
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

10.  Vigabatrin can enhance electroretinographic responses in pigmented and albino rats.

Authors:  James D Akula; Emily R Noonan; Alessia Di Nardo; Tara L Favazza; Nan Zhang; Mustafa Sahin; Ronald M Hansen; Anne B Fulton
Journal:  Doc Ophthalmol       Date:  2015-03-12       Impact factor: 2.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.